C07K 16/32
Against translation products of oncogenes
Official title: against translation products of oncogenes
C07K16/32 (Against translation products of oncogenes) appears on 2,531 US grants and 5,210 published applications in this corpus.
Search patents in C07K- Granted patents
- 2,531
- Published applications
- 5,210
- Assignees
- 1,522
- Inventors
- 8,050
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 4 | 0 |
| 1991 | 3 | 0 |
| 1992 | 4 | 0 |
| 1993 | 3 | 0 |
| 1994 | 4 | 0 |
| 1995 | 4 | 0 |
| 1996 | 10 | 0 |
| 1997 | 15 | 0 |
| 1998 | 27 | 0 |
| 1999 | 25 | 0 |
| 2000 | 21 | 0 |
| 2001 | 20 | 9 |
| 2002 | 21 | 35 |
| 2003 | 7 | 46 |
| 2004 | 18 | 43 |
| 2005 | 16 | 72 |
| 2006 | 13 | 66 |
| 2007 | 20 | 93 |
| 2008 | 29 | 84 |
| 2009 | 40 | 105 |
| 2010 | 41 | 104 |
| 2011 | 51 | 115 |
| 2012 | 49 | 128 |
| 2013 | 55 | 144 |
| 2014 | 93 | 207 |
| 2015 | 94 | 243 |
| 2016 | 122 | 301 |
| 2017 | 151 | 361 |
| 2018 | 169 | 285 |
| 2019 | 186 | 297 |
| 2020 | 201 | 310 |
| 2021 | 165 | 361 |
| 2022 | 178 | 371 |
| 2023 | 178 | 383 |
| 2024 | 201 | 396 |
| 2025 | 178 | 353 |
| 2026 | 108 | 298 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- FOXM1-derived peptide, and vaccine including same29 Sep 2026US 12,747,265 B2Oncotherapy Science, Inc.
- RNA encoding an antibody29 Sep 2026US 12,747,451 B2Cure Vac SE
- Multistep final filtration22 Sep 2026US 12,742,003 B2Hoffmann-La Roche Inc.
- Chimeric antigen receptors to HER2 and methods of use thereof22 Sep 2026US 12,742,020 B2BioAtla, Inc.
- Multi-specific antibodies and methods of making and using thereof15 Sep 2026US 12,735,487 B2Systimmune, Inc.
- Multi-receptor natural killer cells8 Oct 2026US 2026/0308225 A1Board of Regents, The University of Texas System
- Chimeric Cytokine Receptors and Methods of Use8 Oct 2026US 2026/0308235 A1
- Immunotherapeutic proteins8 Oct 2026US 2026/0308271 A1Macfarlane Burnet Institute for Medical Research and Public Health Limited
- Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof8 Oct 2026US 2026/0308274 A1Genentech, Inc.
- Hybrid transient transfection using transposase for high yield product production8 Oct 2026US 2026/0308275 A1Lonza Biologics PLC
Most cited
By later US patents
- Immunoglobulin variants1,380US 5,821,337 AGenentech, Inc. · 1998
- Humanized antibodies and methods for making them1,003US 6,054,297 AGenentech, Inc. · 2000
- Method for making humanized antibodies943US 6,407,213 B1Genentech, Inc. · 2002
- Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof619US 5,587,458 AAronex Pharmaceuticals, Inc. · 1996
- Low pH hydrophobic interaction chromatography for antibody purification599US 5,641,870 AGenentech, Inc. · 1997